Nut allergy sufferers no longer 'living in fear' with new treatment
Peanut flour can help people beat their nut allergies.
King's College London enlisted 21 adults aged between 18 and 40 who have a serious reaction to peanuts for a trial, and they hailed the treatment as "life-changing" and are "no longer living in fear".
The group - of which some members spent between eight and 23 months doing the research, depending on their tolerance and delays due to Covid-19 - were given 0.8mg, 1.5mg and 3mg doses of peanut flour that was mixed with other food under medic supervision.
If they could handle the quantity, the amount of nuts they could consume increased over the course of the weeks and months,
And 67 per cent went on to consume four or five peanuts without having a reaction.
Guy's and St Thomas' NHS Trust's Hannah Hunter, who was the study author, said: 'Many participants who completed the trial told us that the treatment had been life-changing and they were no longer living in fear.'
One person who took part was 28 year old Chris Brookes-Smith.
He used to live in fear of dying because of his peanut allergy, and although he does not like the taste of them, Chris has said it is good he can have four peanuts with his granola - which was recommended by his doctor - every morning.
He is quoted by BBC News as saying: "It's a wonderful feeling.
"I'm no longer afraid of dying."
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Advertiser
2 days ago
- The Advertiser
Australians urged to address falling vaccination rates
With a marked dip in immunisation rates for flu and COVID-19, Australians are being urged to get the jab before winter sets in. Vaccine coverage for influenza sits at just 24.24 per cent nationally and 14 per cent for those under the age of 50. The take-up of COVID boosters has also dropped away significantly in people aged 75 and over, falling from 38 per cent to 32 per cent in the past 12 months. The Australian Medical Association says people need to prioritise conversations with their GP about vaccination against both conditions as well as the similarly widespread respiratory syncytial virus, especially those at greatest Australia's RSV immunisation program has achieved a 57 per cent reduction in hospitalisations among infants, saving the state's health system up to $6.9 million in hospital costs. AMA President Danielle McMullen says its success highlights the power of evidence-based prevention. "These results show what's possible when we get vaccination right, with more babies being kept out of hospital because their parents chose to protect them," she said on Saturday. "The timing could not be more critical with RSV cases climbing since the start of 2025 and children under five most at risk." Dr McMullen says the drop in COVID and flu jab rates is alarming."New COVID-19 strains continue to circulate leading to increased hospitalisations, making regular boosters essential for maintaining protection against severe illness," she said. "We are particularly concerned by (influenza) vaccination rates among Aboriginal and Torres Strait Islander communities, which have declined across all age groups." The national RSV prevention program offers free maternal immunisation and targeted infant protection, while annual influenza jabs provide strong protection, with more than 98 per cent of this year's circulating strains matching vaccine components."The evidence is clear, vaccines work," Dr McMullen said. "But vaccines sitting in fridges don't save lives. We need people to pay attention, particularly parents of young children and older Australians." With a marked dip in immunisation rates for flu and COVID-19, Australians are being urged to get the jab before winter sets in. Vaccine coverage for influenza sits at just 24.24 per cent nationally and 14 per cent for those under the age of 50. The take-up of COVID boosters has also dropped away significantly in people aged 75 and over, falling from 38 per cent to 32 per cent in the past 12 months. The Australian Medical Association says people need to prioritise conversations with their GP about vaccination against both conditions as well as the similarly widespread respiratory syncytial virus, especially those at greatest Australia's RSV immunisation program has achieved a 57 per cent reduction in hospitalisations among infants, saving the state's health system up to $6.9 million in hospital costs. AMA President Danielle McMullen says its success highlights the power of evidence-based prevention. "These results show what's possible when we get vaccination right, with more babies being kept out of hospital because their parents chose to protect them," she said on Saturday. "The timing could not be more critical with RSV cases climbing since the start of 2025 and children under five most at risk." Dr McMullen says the drop in COVID and flu jab rates is alarming."New COVID-19 strains continue to circulate leading to increased hospitalisations, making regular boosters essential for maintaining protection against severe illness," she said. "We are particularly concerned by (influenza) vaccination rates among Aboriginal and Torres Strait Islander communities, which have declined across all age groups." The national RSV prevention program offers free maternal immunisation and targeted infant protection, while annual influenza jabs provide strong protection, with more than 98 per cent of this year's circulating strains matching vaccine components."The evidence is clear, vaccines work," Dr McMullen said. "But vaccines sitting in fridges don't save lives. We need people to pay attention, particularly parents of young children and older Australians." With a marked dip in immunisation rates for flu and COVID-19, Australians are being urged to get the jab before winter sets in. Vaccine coverage for influenza sits at just 24.24 per cent nationally and 14 per cent for those under the age of 50. The take-up of COVID boosters has also dropped away significantly in people aged 75 and over, falling from 38 per cent to 32 per cent in the past 12 months. The Australian Medical Association says people need to prioritise conversations with their GP about vaccination against both conditions as well as the similarly widespread respiratory syncytial virus, especially those at greatest Australia's RSV immunisation program has achieved a 57 per cent reduction in hospitalisations among infants, saving the state's health system up to $6.9 million in hospital costs. AMA President Danielle McMullen says its success highlights the power of evidence-based prevention. "These results show what's possible when we get vaccination right, with more babies being kept out of hospital because their parents chose to protect them," she said on Saturday. "The timing could not be more critical with RSV cases climbing since the start of 2025 and children under five most at risk." Dr McMullen says the drop in COVID and flu jab rates is alarming."New COVID-19 strains continue to circulate leading to increased hospitalisations, making regular boosters essential for maintaining protection against severe illness," she said. "We are particularly concerned by (influenza) vaccination rates among Aboriginal and Torres Strait Islander communities, which have declined across all age groups." The national RSV prevention program offers free maternal immunisation and targeted infant protection, while annual influenza jabs provide strong protection, with more than 98 per cent of this year's circulating strains matching vaccine components."The evidence is clear, vaccines work," Dr McMullen said. "But vaccines sitting in fridges don't save lives. We need people to pay attention, particularly parents of young children and older Australians." With a marked dip in immunisation rates for flu and COVID-19, Australians are being urged to get the jab before winter sets in. Vaccine coverage for influenza sits at just 24.24 per cent nationally and 14 per cent for those under the age of 50. The take-up of COVID boosters has also dropped away significantly in people aged 75 and over, falling from 38 per cent to 32 per cent in the past 12 months. The Australian Medical Association says people need to prioritise conversations with their GP about vaccination against both conditions as well as the similarly widespread respiratory syncytial virus, especially those at greatest Australia's RSV immunisation program has achieved a 57 per cent reduction in hospitalisations among infants, saving the state's health system up to $6.9 million in hospital costs. AMA President Danielle McMullen says its success highlights the power of evidence-based prevention. "These results show what's possible when we get vaccination right, with more babies being kept out of hospital because their parents chose to protect them," she said on Saturday. "The timing could not be more critical with RSV cases climbing since the start of 2025 and children under five most at risk." Dr McMullen says the drop in COVID and flu jab rates is alarming."New COVID-19 strains continue to circulate leading to increased hospitalisations, making regular boosters essential for maintaining protection against severe illness," she said. "We are particularly concerned by (influenza) vaccination rates among Aboriginal and Torres Strait Islander communities, which have declined across all age groups." The national RSV prevention program offers free maternal immunisation and targeted infant protection, while annual influenza jabs provide strong protection, with more than 98 per cent of this year's circulating strains matching vaccine components."The evidence is clear, vaccines work," Dr McMullen said. "But vaccines sitting in fridges don't save lives. We need people to pay attention, particularly parents of young children and older Australians."
Sydney Morning Herald
2 days ago
- Sydney Morning Herald
Patient care must not be compromised by bureaucratic benchmarks
Every three months, the residents of NSW are given a status update on the performance of their state's public health system. The quarterly Bureau of Health Information report paints a picture of how the system is functioning, from the number of ambulance call-outs to wait times in emergency and how long the average patient stays at hospital. Of particular interest since the pandemic – and covered exhaustively by the Herald – has been the elective surgery waitlist, which rose to record lengths when COVID-19 precautions caused the postponement of thousands of non-urgent operations. In the 2023 state election, NSW Labor ran on a platform of reducing the elective surgery waitlist, announcing a surgical taskforce to investigate ways to clear the list, sparing patients from the poor health outcomes that can come from waiting longer than recommended for life-changing operations, including hip and knee replacements, eye surgery, and cardiothoracic procedures. By the end of that year, the number of patients overdue for surgery had declined to pre-pandemic levels. But, as the Herald reported following the release of the latest BHI quarterly data in March, the number of patients overdue for elective surgery in NSW public hospitals tripled between the end of 2023 and the end of 2024. Loading While nowhere near the 18,000-person waitlist left after NSW's Delta lockdown in late 2021, such a sharp upward trend in the number of people waiting too long for operations has not been seen outside of periods of pandemic restrictions. Eye surgeries, joint replacements and tonsillectomies were the procedures with the largest backlogs. Doctors speaking about the release of those figures put the increase down to staff shortages and budget cuts. But, as Herald health editor Kate Aubusson reports today, doubts have been cast over whether the pressure to meet KPIs at some hospitals had led to surgeries being strategically categorised, so they did not appear as overdue on the books. Among the allegations made by doctors at Sydney's RPA and Westmead hospitals, which follow an ABC investigation into similar behaviour at Orange Hospital last month, are that hospitals have been effectively refusing patients because they will not be able to perform their surgery within the recommended timeframe, or changing the categories of patients.
The Age
2 days ago
- The Age
Patient care must not be compromised by bureaucratic benchmarks
Every three months, the residents of NSW are given a status update on the performance of their state's public health system. The quarterly Bureau of Health Information report paints a picture of how the system is functioning, from the number of ambulance call-outs to wait times in emergency and how long the average patient stays at hospital. Of particular interest since the pandemic – and covered exhaustively by the Herald – has been the elective surgery waitlist, which rose to record lengths when COVID-19 precautions caused the postponement of thousands of non-urgent operations. In the 2023 state election, NSW Labor ran on a platform of reducing the elective surgery waitlist, announcing a surgical taskforce to investigate ways to clear the list, sparing patients from the poor health outcomes that can come from waiting longer than recommended for life-changing operations, including hip and knee replacements, eye surgery, and cardiothoracic procedures. By the end of that year, the number of patients overdue for surgery had declined to pre-pandemic levels. But, as the Herald reported following the release of the latest BHI quarterly data in March, the number of patients overdue for elective surgery in NSW public hospitals tripled between the end of 2023 and the end of 2024. Loading While nowhere near the 18,000-person waitlist left after NSW's Delta lockdown in late 2021, such a sharp upward trend in the number of people waiting too long for operations has not been seen outside of periods of pandemic restrictions. Eye surgeries, joint replacements and tonsillectomies were the procedures with the largest backlogs. Doctors speaking about the release of those figures put the increase down to staff shortages and budget cuts. But, as Herald health editor Kate Aubusson reports today, doubts have been cast over whether the pressure to meet KPIs at some hospitals had led to surgeries being strategically categorised, so they did not appear as overdue on the books. Among the allegations made by doctors at Sydney's RPA and Westmead hospitals, which follow an ABC investigation into similar behaviour at Orange Hospital last month, are that hospitals have been effectively refusing patients because they will not be able to perform their surgery within the recommended timeframe, or changing the categories of patients.
